DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease

Brett H. Keeling, Carles Vilariño-Güell, Owen A Ross, Zbigniew K Wszolek, Ryan J. Uitti, Matthew J. Farrer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Variants in the dopamine receptor D3 (DRD3) and HCLS1 binding protein 3 (HS1BP3) have been nominated as risk factors for essential tremor (ET). Although ET and Parkinson disease (PD) are considered different entities, they have many overlapping clinical and pathological features. We aim to evaluate the role of the Ser9Gly variant in DRD3 and Ala265Gly in HS1BP3 in PD development. To this end, we genotyped these two variants in a PD matched case-control series from the United States. Statistical analysis failed to identify significant differences in the frequency of these variants between the case and control groups; therefore our results do not support a role for these DRD3 and HS1BP3 variants in PD.

Original languageEnglish (US)
Pages (from-to)74-75
Number of pages2
JournalNeuroscience Letters
Volume461
Issue number2
DOIs
StatePublished - Sep 11 2009

Fingerprint

Dopamine D3 Receptors
Essential Tremor
Parkinson Disease
Carrier Proteins
Dopamine Receptors
Control Groups

Keywords

  • DRD3
  • Essential tremor
  • HS1BP3
  • Parkinson disease

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. / Keeling, Brett H.; Vilariño-Güell, Carles; Ross, Owen A; Wszolek, Zbigniew K; Uitti, Ryan J.; Farrer, Matthew J.

In: Neuroscience Letters, Vol. 461, No. 2, 11.09.2009, p. 74-75.

Research output: Contribution to journalArticle

Keeling, Brett H. ; Vilariño-Güell, Carles ; Ross, Owen A ; Wszolek, Zbigniew K ; Uitti, Ryan J. ; Farrer, Matthew J. / DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. In: Neuroscience Letters. 2009 ; Vol. 461, No. 2. pp. 74-75.
@article{370dc874ff5e4b6d9fe90894fcb8ee6e,
title = "DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease",
abstract = "Variants in the dopamine receptor D3 (DRD3) and HCLS1 binding protein 3 (HS1BP3) have been nominated as risk factors for essential tremor (ET). Although ET and Parkinson disease (PD) are considered different entities, they have many overlapping clinical and pathological features. We aim to evaluate the role of the Ser9Gly variant in DRD3 and Ala265Gly in HS1BP3 in PD development. To this end, we genotyped these two variants in a PD matched case-control series from the United States. Statistical analysis failed to identify significant differences in the frequency of these variants between the case and control groups; therefore our results do not support a role for these DRD3 and HS1BP3 variants in PD.",
keywords = "DRD3, Essential tremor, HS1BP3, Parkinson disease",
author = "Keeling, {Brett H.} and Carles Vilari{\~n}o-G{\"u}ell and Ross, {Owen A} and Wszolek, {Zbigniew K} and Uitti, {Ryan J.} and Farrer, {Matthew J.}",
year = "2009",
month = "9",
day = "11",
doi = "10.1016/j.neulet.2009.05.084",
language = "English (US)",
volume = "461",
pages = "74--75",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease

AU - Keeling, Brett H.

AU - Vilariño-Güell, Carles

AU - Ross, Owen A

AU - Wszolek, Zbigniew K

AU - Uitti, Ryan J.

AU - Farrer, Matthew J.

PY - 2009/9/11

Y1 - 2009/9/11

N2 - Variants in the dopamine receptor D3 (DRD3) and HCLS1 binding protein 3 (HS1BP3) have been nominated as risk factors for essential tremor (ET). Although ET and Parkinson disease (PD) are considered different entities, they have many overlapping clinical and pathological features. We aim to evaluate the role of the Ser9Gly variant in DRD3 and Ala265Gly in HS1BP3 in PD development. To this end, we genotyped these two variants in a PD matched case-control series from the United States. Statistical analysis failed to identify significant differences in the frequency of these variants between the case and control groups; therefore our results do not support a role for these DRD3 and HS1BP3 variants in PD.

AB - Variants in the dopamine receptor D3 (DRD3) and HCLS1 binding protein 3 (HS1BP3) have been nominated as risk factors for essential tremor (ET). Although ET and Parkinson disease (PD) are considered different entities, they have many overlapping clinical and pathological features. We aim to evaluate the role of the Ser9Gly variant in DRD3 and Ala265Gly in HS1BP3 in PD development. To this end, we genotyped these two variants in a PD matched case-control series from the United States. Statistical analysis failed to identify significant differences in the frequency of these variants between the case and control groups; therefore our results do not support a role for these DRD3 and HS1BP3 variants in PD.

KW - DRD3

KW - Essential tremor

KW - HS1BP3

KW - Parkinson disease

UR - http://www.scopus.com/inward/record.url?scp=67649656094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649656094&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2009.05.084

DO - 10.1016/j.neulet.2009.05.084

M3 - Article

C2 - 19524641

AN - SCOPUS:67649656094

VL - 461

SP - 74

EP - 75

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -